Growth Metrics

Oruka Therapeutics (ORKA) Interest Expenses (2010 - 2022)

Oruka Therapeutics' quarterly Interest Expenses came in at $3000.0 in Q3 2022, up 50.0% quarter-over-quarter from $2000.0 in Q1 2022.

Oruka Therapeutics has reported Interest Expenses for 11 years, with the latest figure at $3000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Interest Expenses changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Jun 2023 stood at $3000.0 (up 50.0% YoY), and the FY2022 full-year result was $5000.0, changed N/A from the prior year.
  • Interest Expenses for Q3 2022 stood at $3000.0, up from $2000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $4000.0 in Q1 2020, with the low at $1000.0 in Q3 2019.
  • Average Interest Expenses over 4 years is $2636.4, with a median of $3000.0 recorded in 2018.
  • Year-over-year, Interest Expenses sank 50.0% in 2019 and jumped 100.0% in 2020.
  • Tracing ORKA's Interest Expenses over 4 years: stood at $2000.0 in 2018, then slumped by 50.0% to $1000.0 in 2019, then jumped by 100.0% to $2000.0 in 2020, then soared by 50.0% to $3000.0 in 2022.
  • The last three Interest Expenses figures came in at $3000.0 (Q3 2022), $2000.0 (Q1 2022), and $2000.0 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 22,854.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -5.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 61,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -332,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 69.29 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 3,000.00
Sep 30, 2022 3,000.00
Mar 31, 2022 2,000.00
Mar 31, 2022 2,000.00
Sep 30, 2020 2,000.00
Sep 30, 2020 2,000.00
Jun 30, 2020 3,000.00
Jun 30, 2020 3,000.00
Mar 31, 2020 4,000.00
Mar 31, 2020 4,000.00
Sep 30, 2019 1,000.00
Sep 30, 2019 1,000.00
Jun 30, 2019 3,000.00
Jun 30, 2019 3,000.00
Mar 31, 2019 3,000.00
Mar 31, 2019 3,000.00
Sep 30, 2018 2,000.00
Sep 30, 2018 2,000.00
Jun 30, 2018 3,000.00
Jun 30, 2018 3,000.00
Mar 31, 2018 3,000.00
Mar 31, 2018 3,000.00
Sep 30, 2017 2,000.00
Sep 30, 2017 2,000.00
Jun 30, 2017 2,000.00
Jun 30, 2017 2,000.00
Mar 31, 2017 2,000.00
Mar 31, 2017 2,000.00
Sep 30, 2015 1,000.00
Sep 30, 2015 1,000.00
Jun 30, 2015 2,000.00
Jun 30, 2015 2,000.00
Mar 31, 2015 1,000.00
Mar 31, 2015 1,000.00
Sep 30, 2014 1,000.00
Sep 30, 2014 1,000.00
Jun 30, 2014 1,000.00
Jun 30, 2014 1,000.00
Mar 31, 2014 1,000.00
Mar 31, 2014 1,000.00
Dec 31, 2013 1,000.00
Dec 31, 2013 1,000.00
Jun 30, 2013 2,000.00
Jun 30, 2013 2,000.00
Mar 31, 2013 1,000.00
Mar 31, 2013 1,000.00
Sep 30, 2012 1,000.00
Sep 30, 2012 1,000.00
Jun 30, 2012 2,000.00
Jun 30, 2012 2,000.00
Mar 31, 2012 1,000.00
Mar 31, 2012 1,000.00
Dec 31, 2011 -4,000.00
Dec 31, 2011 -4,000.00
Sep 30, 2011 2,000.00
Sep 30, 2011 2,000.00
Jun 30, 2011 2,000.00
Jun 30, 2011 2,000.00
Mar 31, 2011 5,000.00
Mar 31, 2011 5,000.00
Dec 31, 2010 1,000.00
Dec 31, 2010 1,000.00
Sep 30, 2010 3,000.00
Sep 30, 2010 3,000.00
Jun 30, 2010 2,000.00
Jun 30, 2010 2,000.00